NCT01738776

Brief Summary

Low Body Mass Index (BMI) is a risk factor for hip fracture, but it is unknown if it is the low BMI per se that increases risk of hip fracture or if specific micro-nutrients contribute. The investigators want to elucidate this aspect in a case control study studying micronutrients in serum and bone turnover markers of hip fracture patients compared with controls of the same age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
184

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 14, 2012

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 30, 2012

Completed
Last Updated

December 4, 2012

Status Verified

November 1, 2012

Enrollment Period

1.6 years

First QC Date

November 14, 2012

Last Update Submit

November 30, 2012

Conditions

Keywords

hip fracturerisk factorsvitamin K1vitamin Dbone turnover markersosteocalcinundercarboxylated osteocalcinbone specific alkaline phosphatase (BALP)insulin like growth factor 1 (IGF1)parathyroid hormone (PTH)

Outcome Measures

Primary Outcomes (1)

  • micronutrient association with increased risk of hip fracture

    Blood was drawn for micronutrient analysis in hip fracture patients and in controls

    At admission

Secondary Outcomes (1)

  • Are micronutrients related to bone turnover markers

    At admission

Study Arms (2)

Cases

Hip fracture patients participating in a randomised controlled trial (RCT) of orthogeriatric care (ClinicalTrials.gov NCT01009268)

Controls

A group of voluntary elderly persons without a history of hip fracture, recruited specifically for this purpose

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Cases: The first 116 patients of an ongoing RCT were included consecutively and examined by blood samples pre operatively for nutrition and hormone analysis. The catchment area for the cases was the city of Oslo, Norway. A control group, at the same age with no history of hip fracture, was drawn at random from inhabitants aged 60 - 100 years (median age 82 years) at the census files of Oslo in 2005.

You may qualify if:

  • Cases are admitted acutely for a femoral neck fracture, a trochanteric or a subtrochanteric femoral fracture.

You may not qualify if:

  • Hip fracture as part of multi-trauma or high energy trauma (defined as a fall from a higher level than 1 metre). One recent fracture in addition to the hip fracture (e.g. radius or shoulder) is acceptable.
  • Regarded as moribund at admittance.
  • Absence of a valid informed consent or assent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oslo, Institute of Clinical Medicine

Oslo, 0424, Norway

Location

Related Publications (2)

  • Torbergsen AC, Watne LO, Frihagen F, Wyller TB, Mowe M. Effects of nutritional intervention upon bone turnover in elderly hip fracture patients. Randomized controlled trial. Clin Nutr ESPEN. 2019 Feb;29:52-58. doi: 10.1016/j.clnesp.2017.11.012. Epub 2018 Oct 30.

  • Torbergsen AC, Watne LO, Wyller TB, Frihagen F, Stromsoe K, Bohmer T, Mowe M. Micronutrients and the risk of hip fracture: Case-control study. Clin Nutr. 2017 Apr;36(2):438-443. doi: 10.1016/j.clnu.2015.12.014. Epub 2015 Dec 23.

Biospecimen

Retention: SAMPLES WITH DNA

For vitamin and hormone analysis serum was collected For some vitamin analysis EDTA blood was collected For RNA analysis fullblood was collected

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Morten Mowe, PhD

    Oslo University Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Nutritionist

Study Record Dates

First Submitted

November 14, 2012

First Posted

November 30, 2012

Study Start

September 1, 2009

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

December 4, 2012

Record last verified: 2012-11

Locations